Functions and regulation of transforming growth factor-beta (TGF-β) in the prostate

European Journal of Cancer

Volumn 41, Issue 6, 2005, Pages 846-857

  Danielpour, David ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; Androgen; Carcinogenesis; IGF I; Prostate; Rapamycin; Smad3; TGF beta; Therapeutics

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; NEUTRALIZING ANTIBODY; PROTEIN KINASE B; RAPAMYCIN; RETINOID; SOMATOMEDIN C; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN; VITAMIN D;

ADVANCED CANCER; CANCER GROWTH; CANCER IMMUNOTHERAPY; CARCINOGENESIS; DISEASE EXACERBATION; FIBROSIS; HORMONAL REGULATION; HORMONE DEPENDENCE; HUMAN; IMMUNE DEFICIENCY; IONIZING RADIATION; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SCLEROSIS;

EID: 16244363070     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.12.027     Document Type: Article

References (195)

1. A.B. Roberts, and M.B. Sporn The transforming growth factor beta 1990 Springer-Verlag New York
2. M.B. Sporn, and A.B. Roberts TGF-beta: problems and prospects Cell Regul 1 12 1990 875 882
3. J.L. Wrana TGF-beta receptors and signalling mechanisms Miner Electrol Metab 24 2-3 1998 120 130
4. J. Massague, J. Andres, and L. Attisano TGF-beta receptors Mol Reprod Dev 32 2 1992 99 104
5. M. Kretzschmar, and J. Massague SMADs: mediators and regulators of TGF-beta signaling Curr Opin Genet Dev 8 1 1998 103 111
6. J. Massague TGFbeta signaling: receptors, transducers, and Mad proteins Cell 85 7 1996 947 950
7. F. Liu, C. Pouponnot, and J. Massague Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes Genes Dev 11 23 1997 3157 3167
8. J. Wrana, and T. Pawson Signal transduction. Mad about SMADs [news; comment] Nature 388 6637 1997 28 29
9. K. Miyazawa, M. Shinozaki, and T. Hara Two major Smad pathways in TGF-beta superfamily signalling Genes Cells 7 12 2002 1191 1204
10. S. Yeh, E.R. Sampson, and D.K. Lee Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer J Formos Med Assoc 99 12 2000 885 894
11. A.I. So, A. Hurtado-Coll, and M.E. Gleave Androgens and prostate cancer World J Urol 21 5 2003 325 337
12. I.Y. Kim, H.J. Ahn, and D.J. Zelner Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues Clin Cancer Res 2 8 1996 1255 1261
13. Y. Guo, S.C. Jacobs, and N. Kyprianou Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer Int J Cancer 71 4 1997 573 579
14. R.H. Williams, A.M. Stapleton, and G. Yang Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study Clin Cancer Res 2 4 1996 635 640
15. Y. Guo, and N. Kyprianou Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells Cell Growth Differ 9 2 1998 185 193
16. Y. Guo, and N. Kyprianou Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis Cancer Res 59 6 1999 1366 1371
17. B. Tang, K. de Castro, and H.E. Barnes Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells Cancer Res 59 19 1999 4834 4842
18. J.A. Eastham, L.D. Truong, and E. Rogers Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer Lab Invest 73 5 1995 628 635
19. Y.I. Henis, A. Moustakas, and H.Y. Lin The types II and III transforming growth factor-beta receptors form homo-oligomers J Cell Biol 126 1 1994 139 154
20. K. Luo, and H.F. Lodish Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction Embo J 15 17 1996 4485 4496
21. K. Luo, and H.F. Lodish Positive and negative regulation of type II TGF-beta receptor signal transduction by autophosphorylation on multiple serine residues Embo J 16 8 1997 1970 1981
22. F. Lopez-Casillas, J.L. Wrana, and J. Massague Betaglycan presents ligand to the TGF beta signaling receptor Cell 73 7 1993 1435 1444
23. T. Tsukazaki, T.A. Chiang, and A.F. Davison SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor Cell 95 6 1998 779 791
24. S. Miura, T. Takeshita, and H. Asao Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA Mol Cell Biol 20 24 2000 9346 9355
25. B.A. Hocevar, A. Smine, and X.X. Xu The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway Embo J 20 11 2001 2789 2801
26. C.A. Moskaluk, R.H. Hruban, and M. Schutte Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma Diagn Mol Pathol 6 2 1997 85 90
27. R.Y. Wu, Y. Zhang, and X.H. Feng Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4 Mol Cell Biol 17 5 1997 2521 2528
28. P. Ten Dijke, M.J. Goumans, and F. Itoh Regulation of cell proliferation by Smad proteins J Cell Physiol 191 1 2002 1 16
29. X. Liu, Y. Sun, and S.N. Constantinescu Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells Proc Natl Acad Sci USA 94 20 1997 10669 10674
30. Y. Yamamura, X. Hua, and S. Bergelson Critical role of smads and AP-1 complex in TGF-{beta}-dependentapoptosis J Biol Chem 2000
31. M.E. Engel, M.A. McDonnell, and B.K. Law Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription J Biol Chem 274 52 1999 37413 37420
32. T. Adachi-Yamada, M. Nakamura, and K. Irie p38 mitogen-activated protein kinase can be involved in transforming growth factor beta superfamily signal transduction in Drosophila wing morphogenesis Mol Cell Biol 19 3 1999 2322 2329
33. A. Atfi, S. Djelloul, and E. Chastre Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling J Biol Chem 272 3 1997 1429 1432
34. A. Axmann, D. Seidel, and T. Reimann Transforming growth factor-beta1-induced activation of the Raf-MEK-MAPK signaling pathway in rat lung fibroblasts via a PKC-dependent mechanism Biochem Biophys Res Commun 249 2 1998 456 460
35. J.D. Brown, M.R. DiChiara, and K.R. Anderson MEKK-1, a component of the stress (stress-activated protein kinase/c- Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells J Biol Chem 274 13 1999 8797 8805
36. M.E. Engel, P.K. Datta, and H.L. Moses Signal transduction by transforming growth factor-beta: a cooperative paradigm with extensive negative regulation J Cell Biochem Suppl 31 1998 111 122
37. R.S. Lo, Y.G. Chen, and Y. Shi The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-beta receptors Embo J 17 4 1998 996 1005
38. C. Dong, Z. Li, and R. Alvarez Jr. Microtubule binding to Smads may regulate TGF beta activity Mol Cell 5 1 2000 27 34
39. Y. Shi, Y.F. Wang, and L. Jayaraman Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling Cell 94 5 1998 585 594
40. Z. Xiao, X. Liu, and H.F. Lodish Importin beta mediates nuclear translocation of Smad 3 J Biol Chem 275 31 2000 23425 23428
41. K. Yagi, D. Goto, and T. Hamamoto Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3 J Biol Chem 274 2 1999 703 709
42. A. Kurisaki, S. Kose, and Y. Yoneda Transforming growth factor-beta induces nuclear import of Smad3 in an importin-beta1 and Ran-dependent manner Mol Biol Cell 12 4 2001 1079 1091
43. L.J. Jonk, S. Itoh, and C.H. Heldin Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer J Biol Chem 273 33 1998 21145 21152
44. E. Piek, C.H. Heldin, and P. Ten Dijke Specificity, diversity, and regulation in TGF-beta superfamily signaling Faseb J 13 15 1999 2105 2124
45. M.J. Charng, P. Kinnunen, and J. Hawker FKBP-12 recognition is dispensable for signal generation by type I transforming growth factor-beta receptors J Biol Chem 271 38 1996 22941 22944
46. M.J. Charng, D. Zhang, and P. Kinnunen A novel protein distinguishes between quiescent and activated forms of the type I transforming growth factor beta receptor J Biol Chem 273 16 1998 9365 9368
47. Y.G. Chen, F. Liu, and J. Massague Mechanism of TGFbeta receptor inhibition by FKBP12 Embo J 16 13 1997 3866 3876
48. J.S. Hu, and E.N. Olson Regulation of differentiation of the BC3H1 muscle cell line through cAMP-dependent and -independent pathways J Biol Chem 263 36 1988 19670 19677
49. F. Ventura, F. Liu, and J. Doody Interaction of transforming growth factor-beta receptor I with farnesyl- protein transferase-alpha in yeast and mammalian cells J Biol Chem 271 24 1996 13931 13934
50. M. Kawabata, T. Imamura, and K. Miyazono Interaction of the transforming growth factor-beta type I receptor with farnesyl-protein transferase-alpha J Biol Chem 270 50 1995 29628 29631
51. I. Griswold-Prenner, C. Kamibayashi, and E.M. Maruoka Physical and functional interactions between type I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A Mol Cell Biol 18 11 1998 6595 6604
52. K.B. Reddy, M.C. Karode, and A.K. Harmony Interaction of transforming growth factor beta receptors with apolipoprotein J/clusterin Biochemistry 35 1 1996 309 314
53. J.G. Leger, M.L. Montpetit, and M.P. Tenniswood Characterization and cloning of androgen-repressed mRNAs from rat ventral prostate Biochem Biophys Res Commun 147 1 1987 196 203
54. G. Jin, and P.H. Howe Transforming growth factor beta regulates clusterin gene expression via modulation of transcription factor c-Fos Eur J Biochem 263 2 1999 534 542
55. L. Choy, and R. Derynck The type II transforming growth factor (TGF)-beta receptor-interacting protein TRIP-1 acts as a modulator of the TGF-beta response J Biol Chem 273 47 1998 31455 31462
56. R. Perlman, W.P. Schiemann, and M.W. Brooks TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation Nat Cell Biol 3 8 2001 708 714
57. T.G. Hofmann, N. Stollberg, and M.L. Schmitz HIPK2 regulates transforming growth factor-beta-induced c-Jun NH (2)-terminal kinase activation and apoptosis in human hepatoma cells Cancer Res 63 23 2003 8271 8277
58. P.K. Datta, A. Chytil, and A.E. Gorska Identification of STRAP, a novel WD domain protein in transforming growth factor-beta signaling J Biol Chem 273 52 1998 34671 34674
59. T.M. Fynan, and M. Reiss Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis Crit Rev Oncog 4 5 1993 493 540
60. S.D. Markowitz, and A.B. Roberts Tumor suppressor activity of the TGF-beta pathway in human cancers [see comments] Cytokine Growth Factor Rev 7 1 1996 93 102
61. R. Parsons, L.L. Myeroff, and B. Liu Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer Cancer Res 55 23 1995 5548 5550
62. L. Garrigue-Antar, T. Munoz-Antonia, and S.J. Antonia Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells Cancer Res 55 18 1995 3982 3987
63. M. Korc Role of growth factors in pancreatic cancer Surg Oncol Clin N Am 7 1 1998 25 41
64. A. Hata, Y. Shi, and J. Massague TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads Mol Med Today 4 6 1998 257 262
65. S. Markowitz, J. Wang, and L. Myeroff Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability [see comments] Science 268 5215 1995 1336 1338
66. J. Wang, L. Sun, and L. Myeroff Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells J Biol Chem 270 37 1995 22044 22049
67. J. Chang, K. Park, and Y.J. Bang Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells Cancer Res 57 14 1997 2856 2859
68. L. Sun, G. Wu, and J.K. Willson Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells J Biol Chem 269 42 1994 26449 26455
69. C.N. Robson, V. Gnanapragasam, and R.L. Byrne Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium J Endocrinol 160 2 1999 257 266
70. J.M. Li, M.A. Nichols, and S. Chandrasekharan Transforming growth factor beta activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site J Biol Chem 270 45 1995 26750 26753
71. A. Iavarone, and J. Massague E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest Mol Cell Biol 19 1 1999 916 922
72. K. Yagi, M. Furuhashi, and H. Aoki c-myc is a downstream target of the Smad pathway J Biol Chem 277 1 2002 854 861
73. J. Seoane, C. Pouponnot, and P. Staller TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b Nat Cell Biol 3 4 2001 400 408
74. P. Staller, K. Peukert, and A. Kiermaier Repression of p15INK4b expression by Myc through association with Miz-1 Nat Cell Biol 3 4 2001 392 399
75. C. Petritsch, H. Beug, and A. Balmain TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G (1) arrest Genes Dev 14 24 2000 3093 3101
76. W.C. Hung, H.C. Chang, and L.Y. Chuang Transforming growth factor beta 1 potently activates CPP32-like proteases in human hepatoma cells Cell Signal 10 7 1998 511 515
77. Y. Shima, K. Nakao, and T. Nakashima Activation of caspase-8 in transforming growth factor-beta-induced apoptosis of human hepatoma cells Hepatology 30 5 1999 1215 1222
78. N. Schrantz, D.A. Blanchard, and M.T. Auffredou Role of caspases and possible involvement of retinoblastoma protein during TGFbeta-mediated apoptosis of human B lymphocytes Oncogene 18 23 1999 3511 3519
79. T.L. Brown, S. Patil, and R.K. Basnett Caspase inhibitor BD-fmk distinguishes transforming growth factor beta-induced apoptosis from growth inhibition Cell Growth Differ 9 10 1998 869 875
80. T.L. Brown, S. Patil, and C.D. Cianci Transforming growth factor beta induces caspase 3-independent cleavage of alphaII-spectrin (alpha-fodrin) coincident with apoptosis J Biol Chem 274 33 1999 23256 23262
81. J.E. Chipuk, M. Bhat, and A.Y. Hsing Bcl-xL blocks transforming growth factor-beta 1-induced apoptosis by inhibiting cytochrome c release and not by directly antagonizing Apaf-1-dependent caspase activation in prostate epithelial cells J Biol Chem 276 28 2001 26614 26621
82. M.M. Ahmed, R.A. Alcock, and D. Chendil Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2 J Biol Chem 277 3 2002 2234 2246
83. C.W. Jang, C.H. Chen, and C.C. Chen TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase Nat Cell Biol 4 1 2002 51 58
84. K. Yamaguchi, S. Nagai, and J. Ninomiya-Tsuji XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway Embo J 18 1 1999 179 187
85. B. Saile, N. Matthes, and H. El Armouche The bcl, NFkappaB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells Eur J Cell Biol 80 8 2001 554 561
86. S. Larisch-Bloch, D. Danielpour, and N.S. Roche Selective loss of the transforming growth factor-beta apoptotic signaling pathway in mutant NRP-154 rat prostatic epithelial cells Cell Growth Differ 11 1 2000 1 10
87. S. Larisch, Y. Yi, and R. Lotan A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif Nat Cell Biol 2 12 2000 915 921
88. H.F. English, R.J. Santen, and J.T. Isaacs Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement Prostate 11 3 1987 229 242
89. S.W. Hayward, J.R. Brody, and G.R. Cunha An edgewise look at basal epithelial cells: three-dimensional views of the rat prostate, mammary gland and salivary gland Differentiation 60 4 1996 219 227
90. S.W. Hayward, L.S. Baskin, and P.C. Haughney Epithelial development in the rat ventral prostate, anterior prostate and seminal vesicle Acta Anat 155 2 1996 81 93
91. I.Y. Kim, H.J. Ahn, and D.J. Zelner Expression and localization of transforming growth factor-beta receptors type I and type II in the rat ventral prostate during regression Mol Endocrinol 10 1 1996 107 115
92. N. Kyprianou, and J.T. Isaacs Activation of programmed cell death in the rat ventral prostate after castration Endocrinology 122 2 1988 552 562
93. N. Kyprianou, and J.T. Isaacs Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death Mol Endocrinol 3 10 1989 1515 1522
94. P. Martikainen, N. Kyprianou, and J.T. Isaacs Effect of transforming growth factor-beta 1 on proliferation and death of rat prostatic cells Endocrinology 127 6 1990 2963 2968
95. M.S. Lucia, M.B. Sporn, and A.B. Roberts The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells J Cell Physiol 175 2 1998 184 192
96. J.E. Chipuk, S.C. Cornelius, and N.J. Pultz The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3 J Biol Chem 277 2 2002 1240 1248
97. A.Y. Hsing, K. Kadomatsu, and M.J. Bonham Regulation of apoptosis induced by transforming growth factor-beta1 in nontumorigenic rat prostatic epithelial cell lines Cancer Res 56 22 1996 5146 5149
98. S.D. Kundu, I.Y. Kim, and T. Yang Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3 (1)-TGF-beta type II dominant negative receptor Prostate 43 2 2000 118 124
99. I.Y. Kim, H.J. Ahn, and D.J. Zelner Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells Cancer Res 56 1 1996 44 48
100. D. Danielpour, K. Kadomatsu, and M.A. Anzano Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate Cancer Res 54 13 1994 3413 3421
101. D. Danielpour Transdifferentiation of NRP-152 rat prostatic basal epithelial cells toward a luminal phenotype: regulation by glucocorticoid, insulin-like growth factor-I and transforming growth factor-beta J Cell Sci 112 Pt 2 1999 169 179
102. S.W. Hayward, P.C. Haughney, and E.S. Lopes The rat prostatic epithelial cell line NRP-152 can differentiate in vivo in response to its stromal environment Prostate 39 3 1999 205 212
103. K. Song, S.C. Cornelius, and D. Danielpour Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II Cancer Res 63 15 2003 4358 4367
104. W.H. Tu, T.Z. Thomas, and N. Masumori The loss of TGF-beta signaling promotes prostate cancer metastasis Neoplasia 5 3 2003 267 277
105. S.W. Hayward, M.A. Rosen, and G.R. Cunha Stromal-epithelial interactions in the normal and neoplastic prostate Br J Urol 79 Suppl 2 1997 18 26
106. G.R. Cunha, S.W. Hayward, and Y.Z. Wang Role of stroma in carcinogenesis of the prostate Differentiation 70 9-10 2002 473 485
107. D.R. Rowley What might a stromal response mean to prostate cancer progression? Cancer Metastasis Rev 17 4 1998 411 419
108. D.M. Peehl, and R.G. Sellers Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells Exp Cell Res 232 2 1997 208 215
109. N.A. Bhowmick, A. Chytil, and D. Plieth TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia Science 303 5659 2004 848 851
110. S.W. Hayward, L.S. Baskin, and P.C. Haughney Stromal development in the ventral prostate, anterior prostate and seminal vesicle of the rat Acta Anat 155 2 1996 94 103
111. M.J. Gerdes, T.D. Dang, and M. Larsen Transforming growth factor-beta1 induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells Endocrinology 139 8 1998 3569 3577
112. S.N. Salm, Y. Koikawa, and V. Ogilvie Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines J Cell Physiol 184 1 2000 70 79
113. N. Kyprianou, and J.T. Isaacs Identification of a cellular receptor for transforming growth factor-beta in rat ventral prostate and its negative regulation by androgens Endocrinology 123 4 1988 2124 2131
114. N. Nishi, H. Oya, and K. Matsumoto Changes in gene expression of growth factors and their receptors during castration-induced involution and androgen-induced regrowth of rat prostates Prostate 28 3 1996 139 152
115. G. Brodin, P. ten Dijke, and K. Funa Increased Smad expression and activation are associated with apoptosis in normal and malignant prostate after castration Cancer Res 59 11 1999 2731 2738
116. S.A. Hayes, M. Zarnegar, and M. Sharma SMAD3 represses androgen receptor-mediated transcription Cancer Res 61 5 2001 2112 2118
117. H.Y. Kang, H.K. Lin, and Y.C. Hu From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells Proc Natl Acad Sci USA 98 6 2001 3018 3023
118. H.Y. Kang, K.E. Huang, and S.Y. Chang Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4 J Biol Chem 277 46 2002 43749 43756
119. E.M. Bruckheimer, and N. Kyprianou Dihydrotestosterone enhances transforming growth factor-beta-induced apoptosis in hormone-sensitive prostate cancer cells Endocrinology 142 6 2001 2419 2426
120. E.M. Bruckheimer, and N. Kyprianou Bcl-2 antagonizes the combined apoptotic effect of transforming growth factor-beta and dihydrotestosterone in prostate cancer cells Prostate 53 2 2002 133 142
121. J.L. Carey, L.M. Sasur, and H. Kawakubo Mutually antagonistic effects of androgen and activin in the regulation of prostate cancer cell growth Mol Endocrinol 18 3 2004 696 707
122. M.J. Linja, K.J. Savinainen, and O.R. Saramaki Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer Cancer Res 61 9 2001 3550 3555
123. G.G. Kuiper, and A.O. Brinkmann Phosphotryptic peptide analysis of the human androgen receptor: detection of a hormone-induced phosphopeptide Biochemistry 34 6 1995 1851 1857
124. P.W. Hsiao, D.L. Lin, and R. Nakao The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator J Biol Chem 274 29 1999 20229 20234
125. P.W. Hsiao, and C. Chang Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells J Biol Chem 274 32 1999 22373 22379
126. N. Fujimoto, S. Yeh, and H.Y. Kang Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate J Biol Chem 274 12 1999 8316 8321
127. H.Y. Kang, S. Yeh, and N. Fujimoto Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor J Biol Chem 274 13 1999 8570 8576
128. X. Wang, S. Yeh, and G. Wu Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells J Biol Chem 276 44 2001 40417 40423
129. K. Fronsdal, N. Engedal, and T. Slagsvold CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1 J Biol Chem 273 48 1998 31853 31859
130. A. Bubulya, S.C. Wise, and X.Q. Shen c-Jun can mediate androgen receptor-induced transactivation J Biol Chem 271 40 1996 24583 24589
131. J. Schneikert, H. Peterziel, and P.A. Defossez Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression J Biol Chem 271 39 1996 23907 23913
132. H. Hong, K. Kohli, and M.J. Garabedian GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors Mol Cell Biol 17 5 1997 2735 2744
133. T. Ikonen, J.J. Palvimo, and O.A. Janne Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators J Biol Chem 272 47 1997 29821 29828
134. H. Poukka, P. Aarnisalo, and U. Karvonen Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription J Biol Chem 274 27 1999 19441 19446
135. H.K. Lin, S. Yeh, and H.Y. Kang Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor Proc Natl Acad Sci USA 98 13 2001 7200 7205
136. P.J. bKaplan, S. Mohan, and P. Cohen The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model Cancer Res 59 9 1999 2203 2209
137. E. Giovannucci Insulin-like growth factor-I and binding protein-3 and risk of cancer Horm Res 51 Suppl 3 1999 34 41
138. T. Nickerson, M. Pollak, and H. Huynh Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2, 3, 4 and 5 Endocrinology 139 2 1998 807 810
139. Z. Culig, A. Hobisch, and M.V. Cronauer Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor Cancer Res 54 20 1994 5474 5478
140. J.M. Chan, M.J. Stampfer, and E. Giovannucci Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study Science 279 5350 1998 563 566
141. P. Stattin, A. Bylund, and S. Rinaldi Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study J Natl Cancer Inst 92 23 2000 1910 1917
142. J. DiGiovanni, K. Kiguchi, and A. Frijhoff Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice Proc Natl Acad Sci USA 97 7 2000 3455 3460
143. R. Baserga, and A. Morrione Differentiation and malignant transformation: two roads diverged in a wood J Cell Biochem Suppl 32-33 1999 68 75
144. R. Baserga, A. Hongo, and M. Rubini The IGF-I receptor in cell growth, transformation and apoptosis Biochim Biophys Acta 1332 3 1997 F105 F126
145. R. Baserga The IGF-I receptor in cancer research Exp Cell Res 253 1 1999 1 6
146. R. Baserga The insulin-like growth factor I receptor: a key to tumor growth Cancer Res 55 2 1995 249 252
147. K.M. Nicholson, and N.G. Anderson The protein kinase B/Akt signalling pathway in human malignancy Cell Signal 14 5 2002 381 395
148. X. Wu, K. Senechal, and M.S. Neshat The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway Proc Natl Acad Sci USA 95 26 1998 15587 15591
149. Y. Wen, M.C. Hu, and K. Makino HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway Cancer Res 60 24 2000 6841 6845
150. M. Sharma, W.W. Chuang, and Z. Sun Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation J Biol Chem 277 34 2002 30935 30941
151. J.R. Graff, B.W. Konicek, and A.M. McNulty Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression J Biol Chem 275 32 2000 24500 24505
152. J. Li, C. Yen, and D. Liaw PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 5308 1997 1943 1947
153. P. Cairns, K. Okami, and S. Halachmi Frequent inactivation of PTEN/MMAC1 in primary prostate cancer Cancer Res 57 22 1997 4997 5000
154. H. Suzuki, D. Freije, and D.R. Nusskern Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues Cancer Res 58 2 1998 204 209
155. Y.E. Whang, X. Wu, and H. Suzuki Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression Proc Natl Acad Sci USA 95 9 1998 5246 5250
156. R.J. Vlietstra, D.C. van Alewijk, and K.G. Hermans Frequent inactivation of PTEN in prostate cancer cell lines and xenografts Cancer Res 58 13 1998 2720 2723
157. E.A. Facher, and J.C. Law PTEN and prostate cancer J Med Genet 35 9 1998 790
158. V. Stambolic, A. Suzuki, and J.L. de la Pompa Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Cell 95 1 1998 29 39
159. P. Blume-Jensen, and T. Hunter Oncogenic kinase signalling Nature 411 6835 2001 355 365
160. K. Song, S.C. Cornelius, and M. Reiss Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2 J Biol Chem 278 40 2003 38342 38351
161. B.K. Law, A. Chytil, and N. Dumont Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene- transformed, and human cancer cells Mol Cell Biol 22 23 2002 8184 8198
162. M. Huse, T.W. Muir, and L. Xu The TGF beta receptor activation process: an inhibitor- to substrate-binding switch Mol Cell 8 3 2001 671 682
163. A.R. Conery, Y. Cao, and E.A. Thompson Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis Nat Cell Biol 6 4 2004 366 372
164. I. Remy, A. Montmarquette, and S.W. Michnick PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3 Nat Cell Biol 6 4 2004 358 365
165. K.C. Arden FoxO: linking new signaling pathways Mol Cell 14 4 2004 416 418
166. J. Seoane, H.V. Le, and L. Shen Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation Cell 117 2 2004 211 223
167. M.C. Birchenall-Roberts, T. Fu, and O.S. Bang Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins. A molecular link of two tumor suppressor pathways J Biol Chem 279 24 2004 25605 25613
168. A.B. Roberts Molecular and cell biology of TGF-beta Miner Electrolyte Metab 24 2-3 1998 111 119
169. D. Danielpour, and M.B. Sporn Differential inhibition of transforming growth factor beta1 and beta 2 activity by alpha 2-macroglobulin J Biol Chem 265 12 1990 6973 6977
170. Q. Liu, T.Y. Ling, and H.S. Shieh Identification of the high affinity binding site in transforming growth factor-beta involved in complex formation with alpha 2-macroglobulin. Implications regarding the molecular mechanisms of complex formation between alpha 2-macroglobulin and growth factors, cytokines, and hormones J Biol Chem 276 49 2001 46212 46218
171. J. LaMarre, M.A. Hayes, and G.K. Wollenberg An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice J Clin Invest 87 1 1991 39 44
172. L.M. Wakefield, D.M. Smith, and K.C. Flanders Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences J Biol Chem 263 16 1988 7646 7654
173. E.J. Ehrhart, P. Segarini, and M.L. Tsang Latent transforming growth factor beta1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation Faseb J 11 12 1997 991 1002
174. M.H. Barcellos-Hoff Radiation-induced transforming growth factor beta and subsequent extracellular matrix reorganization in murine mammary gland Cancer Res 53 17 1993 3880 3886
175. K.B. Ewan, R.L. Henshall-Powell, and S.A. Ravani Transforming growth factor-beta1 mediates cellular response to DNA damage in situ Cancer Res 62 20 2002 5627 5631
176. K.C. Flanders, C.D. Sullivan, and M. Fujii Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation Am J Pathol 160 3 2002 1057 1068
177. D. Danielpour Induction of transforming growth factor-beta autocrine activity by all-trans-retinoic acid and 1 alpha,25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells J Cell Physiol 166 1 1996 231 239
178. S. Murthy, and N.L. Weigel 1alpha,25-dihydroxyvitamin D3 induced growth inhibition of PC-3 prostate cancer cells requires an active transforming growth factor beta signaling pathway Prostate 59 3 2004 282 291
179. M.S. Lucia, M.A. Anzano, and M.V. Slayter Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate Cancer Res 55 23 1995 5621 5627
180. A. Kopp, W. Jonat, and M. Schmahl Transforming growth factor beta 2 (TGF-beta 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen Cancer Res 55 20 1995 4512 4515
181. Y. Liang, M.A. Eid, and F. El Etreby Mifepristone-induced secretion of transforming growth factor beta1-induced apoptosis in prostate cancer cells Int J Oncol 21 6 2002 1259 1267
182. J. LaMarre, G.K. Wollenberg, and J. Gauldie Alpha 2-macroglobulin and serum preferentially counteract the mitoinhibitory effect of transforming growth factor-beta 2 in rat hepatocytes Lab Invest 62 5 1990 545 551
183. H.L. Adler, M.A. McCurdy, and M.W. Kattan Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma J Urol 161 1 1999 182 187
184. A.H. Shah, W.B. Tabayoyong, and S.D. Kundu Suppression of tumor metastasis by blockade of transforming growth factor beta signaling in bone marrow cells through a retroviral-mediated gene therapy in mice Cancer Res 62 24 2002 7135 7138
185. A.B. Roberts, and L.M. Wakefield The two faces of transforming growth factor beta in carcinogenesis Proc Natl Acad Sci USA 100 15 2003 8621 8623
186. L.M. Wakefield, and A.B. Roberts TGF-beta signaling: positive and negative effects on tumorigenesis Curr Opin Genet Dev 12 1 2002 22 29
187. Y.A. Yang, O. Dukhanina, and B. Tang Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects J Clin Invest 109 12 2002 1607 1615
188. S.N. Sehgal, K. Molnar-Kimber, and T.D. Ocain Rapamycin: a novel immunosuppressive macrolide Med Res Rev 14 1 1994 1 22
189. M. Hidalgo, and E.K. Rowinsky The rapamycin-sensitive signal transduction pathway as a target for cancer therapy Oncogene 19 56 2000 6680 6686
190. J.P. Dutcher Mammalian target of rapamycin inhibition Clin Cancer Res 10 18 2004 6382S 6387S
191. S. Chan Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer Br J Cancer 2004
192. C.J. Sabers, M.M. Martin, and G.J. Brunn Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells J Biol Chem 270 2 1995 815 822
193. M.C. Lorenz, and J. Heitman TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin J Biol Chem 270 46 1995 27531 27537
194. T. Wang, B.Y. Li, and P.D. Danielson The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors Cell 86 3 1996 435 444
195. H.G. van der Poel, C. Hanrahan, and H. Zhong Rapamycin induces Smad activity in prostate cancer cell lines Urol Res 30 6 2003 380 386